FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/06/2022
Voltar para busca
Dado oficial do USPTO
R REYON
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
12/06/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35
Data de depósito
09/09/2020
Data de registro
30/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/11/2021
Última transação
30/11/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
KR
Examinador
SEVERSON, JUSTIN
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the term "REYON" in black stylized font below a stylized letter "R" in blue.
Titulares e representantes
Titulares
REYON PHARMACEUTICAL CO.,LTD.
Representantes
COREY A. DONALDSON FERGUSON CASE ORR PATERSON LLP
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical agents affecting metabolism; vitamin and mineral preparations for medical use; crude medicinesmedicines for the treatment and prevention of atopic skin diseaseobesitydigestive disordersimmune system related diseases and disorders; anti-inflammatory and antipyretic preparations; cardiovascular pharmaceutical preparations; dietetic food supplements; food for babies; preparations of microorganisms for medical or veterinary use; medical and surgical plasters; pharmaceutical and veterinary preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system related diseases and disorders; pharmaceutical and veterinary preparations for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations for ocular and intraocular surgery; pharmaceutical and veterinary preparations acting on the central nervous system; pharmaceutical and veterinary preparations for the prevention of osteoporosis; pharmaceutical and veterinary preparations for use in urology; pharmaceutical and veterinary preparationsdrug delivery systems comprising polymer-based oral tablets for the continuous release of therapeutic agents; pharmaceutical and veterinary preparations for use in the anesthesia; pharmaceutical and veterinary preparations for diagnostic purposes; pharmaceutical and veterinary preparations for the peripheral nervous system; pharmaceutical and veterinary preparations for digestive organs; pharmaceutical and veterinary preparations for anti-fungal treatment; nutraceutical preparations for therapeutic or medical purposes; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs; all aforementioned goods sold only to hospitals or other healthcare institutions and to pharmaceutical companies
Classe 35
Wholesale store services featuring dietary supplements for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring drugs for medical purposes for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring medicines for human purposes for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; business intermediary services relating to mail order by telecommunicationsmail order pharmacy services for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring analgesics for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/05/2022
FIMP
FINAL DISPOSITION PROCESSED
20/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
30/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/09/2021
PUBO
PUBLISHED FOR OPPOSITION
14/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2021
RFNT
REFUSAL PROCESSED BY IB
21/02/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/02/2021
RFRR
REFUSAL PROCESSED BY MPU
04/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/01/2021
CNRT
NON-FINAL ACTION WRITTEN
21/01/2021
DOCK
ASSIGNED TO EXAMINER
19/01/2021
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/11/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace R REYON ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.